Novartis | L'Utile Ante Imposte

Pre Tax Profit Cambiamento Data
Canopy Growth CAD -135341000 95.5M 2023-09
Gilead Sciences USD 2.59B 586M 2023-12
Pacira USD 48.15M 121K 2023-09
Perrigo USD 107.6M 14.1M 2023-09
Prestige Brands USD 69.58M 845K 2023-12
Roche Holding CHF 10.33B 1.48B 2023-06
Sanofi EUR 3.96B 1.2B 2023-09
Supernus Pharmaceuticals USD 990K 38.1M 2023-12



Novartis L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.